Accounting for intra-species variability in drug exposure and residues with physiologically-based pharmacokinetic modeling

被引:0
|
作者
Taverne, F. J. [1 ]
Gehring, R. [1 ]
Meijer, B. [2 ]
Heederik, D. J. J. [1 ]
Mouton, J. W. [3 ]
Kramer, N. I. [1 ]
机构
[1] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands
[2] Dopharma Res BV, Raamsdonksveer, Netherlands
[3] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P13.6
引用
收藏
页码:148 / 148
页数:1
相关论文
共 50 条
  • [1] PARAMETER VARIABILITY AND THE INTERPRETATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING RESULTS
    SPEAR, RC
    BOIS, FY
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 : 61 - 66
  • [2] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug–Drug Interactions
    Ruben de Kanter
    Patricia N. Sidharta
    Stéphane Delahaye
    Carmela Gnerre
    Jerome Segrestaa
    Stephan Buchmann
    Christopher Kohl
    Alexander Treiber
    Clinical Pharmacokinetics, 2016, 55 : 369 - 380
  • [3] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING FOR PREGNANCY
    Liu, X.
    Leong, R.
    Buckart, G.
    Dallmann, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S117 - S117
  • [4] Physiologically-based pharmacokinetic models to predict drug exposure during pregnancy
    Ait-Chikh, Celia
    Page, Guylene
    Thoreau, Vincent
    ANNALES PHARMACEUTIQUES FRANCAISES, 2024, 82 (02): : 236 - 242
  • [5] A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children
    Sjogren, Erik
    Tarning, Joel
    Barnes, Karen, I
    Jonsson, E. Niclas
    PHARMACEUTICS, 2021, 13 (02) : 1 - 23
  • [6] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions
    de Kanter, Ruben
    Sidharta, Patricia N.
    Delahaye, Stphane
    Gnerre, Carmela
    Segrestaa, Jerome
    Buchmann, Stephan
    Kohl, Christopher
    Treiber, Alexander
    CLINICAL PHARMACOKINETICS, 2016, 55 (03) : 369 - 380
  • [7] EFFECT OF PARAMETER VARIABILITY ON PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL PREDICTED DRUG CONCENTRATIONS
    VARKONYI, P
    BRUCKNER, JV
    GALLO, JM
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (03) : 381 - 384
  • [8] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF ATORVASTATIN AND RELATED SPECIES AND PREDICTION OF DRUG-DRUG INTERACTIONS IN HUMANS.
    Morse, B. L.
    Alberts, J. J.
    Kolur, A.
    Posada, M. M.
    Tham, L.
    Loghin, C.
    Hall, S. D.
    Dickinson, G. L.
    Hillgren, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S63 - S64
  • [9] Pharmacokinetics and Physiologically-Based Pharmacokinetic Modeling of Nanoparticles
    Yang, Raymond S. H.
    Chang, Louis W.
    Yang, Chung Shi
    Lin, Pinpin
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2010, 10 (12) : 8482 - 8490
  • [10] Physiologically-based pharmacokinetic modeling of pyrene in the rat
    Haddad, S
    Withey, J
    Laparé, S
    Law, F
    Krishnan, K
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 1998, 5 (04) : 245 - 255